Sign inJoin waitlistJoin the waitlist

Naga Chalasani

David W. Crabb Professor of Gastroenterology and Hepatology · Indiana University School of Medicine

Credentials: · · · ·

History

Indiana University School of Medicine
Present
Indiana University School of Medicine
Present
Indiana University School of Medicine
Present

Gastroenterology
Emory University School of Medicine
1997–2000
Internal Medicine
Emory University School of Medicine
1994–1997
Emory University School of Medicine
1990–1994

Research

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Hepatology · 2018 · First of 9 authors · 5,460 citations
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of…
Hepatology · 2012 · First of 8 authors · Corresponding · 2,732 citations
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
New England Journal of Medicine · 2010 · 2,636 citations

Raj Vuppalanchi
106 papers · 2 as a fellow
Marwan Ghabril
92 papers
Arun Sanyal
85 papers
Samer Gawrieh
79 papers
David Kleiner
60 papers
Eric Orman
60 papers
Eduardo Vilar
57 papers · 29 as a resident
Archita Desai
52 papers
Lauren Nephew
52 papers · 29 as a fellow
Robert Fontana
50 papers
Rohit Loomba
50 papers
Suthat Liangpunsakul
48 papers · 4 as a fellow

Grants

HIV MASLD Clinical Research Network (HCRN)
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $8.7M · Indiana University Indianapolis
2020–2030
Integrated Therapies for Alcohol Use and ALD (ITAALD) Network - IU Clinical Center
National Institute on Alcohol Abuse and Alcoholism · U01
Contact PI · $8.1M · Indiana University Indianapolis
2012–2029
IU Clinical Center: Drug Induced Liver Injury Network
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $7.5M · Indiana University Indianapolis
2003–2028
Collaborative Clinical Research in Nonalcoholic Steatohepatitis
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $10.2M · Indiana University Indianapolis
2002–2027

Clinical trials

Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)
Principal investigator · Completed · Phase 2
Naga P. Chalasani
2020–2022
Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)
Principal investigator · Terminated · Phase 2
Naga P. Chalasani
2014–2018
Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Principal investigator · Completed · Phase 1
Galectin Therapeutics Inc.
2013–2015
Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium
Principal investigator · Completed
Indiana University
2013–2019